Histone Deacetylase Inhibition Overcomes Drug Resistance through a miRNA-Dependent Mechanism

1Oncology, Johns Hopkins University School of Medicine.
Molecular Cancer Therapeutics (Impact Factor: 6.11). 08/2013; 12(10). DOI: 10.1158/1535-7163.MCT-13-0418
Source: PubMed

ABSTRACT The treatment of specific tumor cell lines with poly- and oligoamine analogues results in a super-induction of polyamine catabolism that is associated with cytotoxicity; however, other tumor cells demonstrate resistance to analogue treatment. Recent data indicate that some of these analogues also have direct epigenetic effects. We therefore sought to determine the effects of combining specific analogues with an epigenetic targeting agent in phenotypically resistant human lung cancer cell lines. We demonstrate that the histone deacetylase inhibitor MS-275 when combined with (N1, N11)-bisethylnorspermine (BENSpm) or (N1, N12)-bis(ethyl)-cis-6,7-dehydrospermine tetrahydrochloride (PG-11047) synergistically induces the polyamine catabolic enzyme spermidine/spermine N1-acetyltransferase (SSAT), a major determinant of sensitivity to the antitumor analogues. Evidence indicates that the mechanism of this synergy includes reactivation of miR-200a, which targets and destabilizes kelch-like ECH-associated protein 1 (KEAP1) mRNA, resulting in the translocation and binding of nuclear factor (erythroid-derived 2)-like 2 (NRF2) to the polyamine-responsive element of the SSAT promoter. This transcriptional stimulation combined with positive regulation of SSAT mRNA and protein by the analogues results in decreased intracellular concentrations of natural polyamines and growth inhibition. The finding that an epigenetic targeting agent is capable of inducing a rate-limiting step in polyamine catabolism to overcome resistance to the antitumor analogues represents a completely novel chemotherapeutic approach. This is also the first demonstration of miRNA-mediated regulation of the polyamine catabolic pathway. Furthermore, the individual agents used in this study have been investigated clinically; therefore, translation of these combinations into the clinical setting holds promise.


Available from: Patrick M. Woster, May 23, 2015
1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: Polyamines at physiological concentration can condense DNA, chromatin and promote B to Z DNA transitions. These properties of polyamines are crucial to the molecular organization and functional control of DNA and thus have very significant implications in the control of cellular functions. The structure of polyamines plays an important role in the binding of DNA and chromatin and it is not merely the charge, but a specific chain length of methylene (-CH2) groups that is required. Acetylation of polyamines seems to be an important mode of regulating polyamine-chromatin interaction. Purified histone acetyltransferase also possesses polyamine acetylation activity, thus histones and polyamine acetylation may occur in tandem to alter the structure/function of the nucleosome thereby regulating DNA replication and transcription. Acetylation as a means to diminish the number of charges on polyamine molecules serves as an ordered mechanism to control DNA replication and transcription in vivo. The results on the involvement of polyamines and their analogs in condensation of DNA and B to Z DNA transition correlate well with the conclusions drawn from experiments designed to observe the in vivo effects of polyamines and their analogs on the growth of prokaryotic and eukaryotic cells. For example, any change in the hydrogen bonding capacity of polyamines leads to a marked reduction in protein synthesis and the growth rate of polyamine depleted cells. A minimal level of polyamines is required for cells to move from G1 through S phase and these amines are directly involved in the DNA synthetic phase of the cell cycle. A nexus between polyamines and nucleic acids appears crucial to the cellular function(s) of polyamines.
    Molecular and Cellular Biochemistry 03/1991; 100(2):129-40. DOI:10.1007/BF00234162 · 2.39 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Eight analogues of 1N,12N-bisethylspermine (BES) with restricted conformations were synthesized in the search for new spermine mimetics with cytotoxic activities. By replacing the central butane segment of BES with a 1,2-disubstituted cyclopropane ring, a pair of cis/trans-isomers was obtained that introduced a spatial constraint in the otherwise freely mobile butane chain. An analogous pair of isomers was obtained when the butane segment was replaced with a 1, 2-disubstituted cyclobutane ring or with a 2-butene residue. The six new BES analogues thus obtained (three pairs of cis/trans-isomers) were growth inhibitory at low-micromolar concentrations against four human tumor cell lines (A549, HT-29, U251MG, and DU145) but were less growth inhibitory against two other human tumor cell lines (PC-3 and MCF7). 1N,12N-Bisethylspermyne, where the central butane segment of BES was replaced by the rigid 2-butyne segment, was devoid of growth inhibitory activity against five of the six human cell lines studied (DU145 being the only exception), a clear indication of the importance of conformational mobility at the 4N, 9N-butane segment of BES for its biological activity. When the butane segment was replaced by a benzene-1,2-dimethyl residue, the resulting BES analogue was devoid of growth inhibitory activity despite its cisoid conformation. The cytotoxicity of the analogues does not seem to be directly related to their uptake by the cells or to their effects on cellular polyamine levels. BES analogues with restricted conformations but which contained the equivalent of a two-carbon unit, rather than the natural four-carbon unit, at the central segment, such as 1,2-diaminocyclopropyl or 1, 2-diaminocyclobutyl derivatives, were devoid of growth inhibitory effects at the concentrations studied. The development of conformationally restricted polyamine analogues appears to show promise in the further quest for polyamine-related therapeutic agents with specificity of action.
    Journal of Medicinal Chemistry 12/1998; 41(24):4723-32. DOI:10.1021/jm980172v · 5.48 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We have investigated the induction of an important polyamine metabolic enzyme, spermidine/spermine N1-acetyltransferase, in two human lung cancer cell lines which respond differently to treatment with the bis(ethyl)polyamine analogues. The human small cell lung carcinoma line NCI H82 has previously been shown to be minimally affected by treatment with these analogues, whereas the large cell undifferentiated lung carcinoma line, NCI H157, responds in a rapid cytotoxic manner (R.A. Casero, Jr., S. J. Ervin, P. Celano, S. B. Baylin, and R. J. Bergeron, Cancer Res., 49:639-643, 1989). The mechanisms underlying the differential response are unknown. In the responsive NCI H157 cells, the bis(ethyl)polyamines were found to induce spermidine/spermine N1-acetyltransferase in a time- and dose-dependent manner to maximum levels greater than 1700-fold over baseline. By contrast, the unresponsive NCI H82 cells exhibit minimal induction of spermidine/spermine N1-acetyltransferase to less than 7-fold increase after bis(ethyl)polyamine treatment, regardless of time or concentration examined. The results of the current study suggest that the differential induction of this key enzyme, which is rate limiting in the back conversion pathway of polyamine metabolism, may play a role in determining cell specific to the bis(ethyl)polyamine analogues.
    Cancer Research 08/1989; 49(14):3829-33. · 9.28 Impact Factor